Image pharmaphorum Editor News Keytruda approved for combination lung cancer therapy The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC). News Amazon sells exclusive diabetes and hypertension devices Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home. News UK opens doors to cannabis-based therapies via NHS Medical cannabis is available to certain patients across the UK for the first time from today. News FDA approves biosimilar of blockbuster Humira A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food and Drug Administration (FDA). Load more results
News Keytruda approved for combination lung cancer therapy The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).
News Amazon sells exclusive diabetes and hypertension devices Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home.
News UK opens doors to cannabis-based therapies via NHS Medical cannabis is available to certain patients across the UK for the first time from today.
News FDA approves biosimilar of blockbuster Humira A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food and Drug Administration (FDA).
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
